Cell, 1997. 89(2): p. 251-61. https://pubmed.ncbi.nlm.nih.gov/9108480/ 2. Front Mol Neurosci, 2020. 13: p. 5. https://pubmed.ncbi.nlm.nih.gov/32038168/ 3. Cell, 2021. 184(4): p. 931-942.e18. https://pubmed.ncbi.nlm.nih.gov/33571431/ 6. J Neurosci, 2019. 39(42): p. 8291-8304. https://pubmed.ncbi.nlm.nih.gov/31308097/ 8. Genomics, 2021. 113(4): p. 2134-2144. https://pubmed.ncbi.nlm.nih.gov/33845140/

Congratulations to Dr. Don't forget to mark your calendars for July 21st, as the upcoming Dr. Be sure to subscribe to Dr. GPCR Newsletter for updates! Industry News Dr. Associate Director / Director, Clinical Operations Professor in Cardiovascular Pharmacology Explore Dr

clinical parameters such as alpha-fetoprotein and tumor grade in the HCC patients; (c) besides HCC (p was found to be an important factor for survival in four other cancers (clear renal cell carcinoma: p < 0.001, lung adenocarcinoma: p = 0.004, mesothelioma: p = 0.039, ovarian serous cystadenocarcinoma: p = 0.048); (d) RGS20 was found to be significantly associated with some tumor-related signaling pathways

On September 22nd, we're hosting the Dr. GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Make sure to stay in the loop with the Dr. GPCR Newsletter! Molecular Pharmacology Director, Clinical Data Management Director, Discovery Toxicology Postdoc Fellow - Dr Robert Lefkowitz Lab Postdoc Fellow - Dr. Robert Lefkowitz Lab Explore Dr. GPCR Ecosystem

In the foundational lesson of Terry’s Corner , Dr.

At Dr. Thank you for sharing your perspective and helping us shape the future of the Dr. GPCR ecosystem! Best, Yamina & the Dr.

Dr. Hunter P. Persechino M, Hedderich JB, Kolb P, Hilger D. Changeux J-P, Christopoulos A. González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, et al.

It's starting to look a lot like Christmas at Dr. GPCR! coupling between extracellular and transmembrane domains modulates holo-adhesion GPCR function Szymon P

of patients showed high GPER expression and significant correlation with the mRNA subtype of TNBC (P  = 0.001), total metastatic events (P = 0.019) and liver metastasis (P = 0.011). interval of 67.1 months, a significant trend towards reduced distant metastasis-free survival (DMFS) (P 

J., Pardon, E., Casarosa, P., Chae, P. S., Devree, B. T., Rosenbaum, D. M., Thian, F. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. C., Gmeiner, P., Steyaert, J., Weis, W. I., Garcia, K. C., Wess, J., & Kobilka, B. K. (2013). D., Tworak, A., Watanabe, K., Pardon, E., Steyaert, J., Kandori, H., Katayama, K., Kiser, P.

This week's highlights: Dr. Terence E. Protein-Biased Agonists for Intracellular Angiotensin Receptors Promote Collagen Secretion in Myofibroblasts' Dr September 22: Don't miss the Dr. GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Subscribe to Dr. GPCR Newsletter to receive more insights! Director, Regulatory Affairs Research Scientist/Senior Scientist I - Molecular Pharmacology Explore Dr

This week's highlights: Drs. Dr. Did you know that as a premium member, you enjoy exclusive access to recorded talks from our Dr. Subscribe now to gain access to exclusive insights from Dr. GPCR Newsletter! Research Fellow Research Technician II - Surgery Post-Doc Research Associate Research Technician Explore Dr

Save the dates: November 17: Join our final Dr. Get the inside scoop by subscribing to our monthly Dr. GPCR Newsletter, and watch our latest video featuring Dr. Kathleen Caron. Pharmaceuticals In vivo Antibody Discovery Research Scientist In Vitro Biologist/Molecular Pharmacologist Explore Dr

Step into the world of drug discovery with Dr.

and an analysis using quantitative PCR showed that it was expressed at all developmental stages of P. of double-stranded RNA in an RNA interference assay indicated that PxOctβ3 regulates development in P. This study demonstrated the pharmacological properties and functions of PxOctβ3 in P. xylostella, thus

This week's GPCR papers feature a publication by Dr. Robert J Lefkowitz. Join us tomorrow, July 21, in the Dr. Remember to subscribe to Dr. GPCR Newsletter for updates! Lab Clinical Trial Associate Research Scientist/Senior Scientist I - Molecular Pharmacology Explore Dr

Proc Natl Acad Sci U S A, 2020. 117(35): p. 21723-21730. 2.      Proceedings of the National Academy of Sciences, 2017. 114(14): p. 3756-3761. 3.      Mol Pharmacol, 2017. 91(5): p. 533-544.

This week's GPCR papers feature publications from Drs. attention to some of our events and resources: Please mark your calendars for July 21st for our next Dr Stay updated with Dr. GPCR News by subscribing to our monthly newsletter. Our founder Dr. Yamina A. Associate Director / Director, Clinical Operations Postdoctoral Research Associate Lab Manager Explore Dr

Save the date and join us next week, May 19th, 2023 for the Dr. Stay informed with the latest Dr. GPCR News by subscribing to our monthly newsletter. 2023 Neurocrine Biosciences Reports First Quarter 2023 Financial Results Find Therapeutics welcomes Dr Expectations, EPS Lags “As Precision Medicine is critical, we cannot think about one size fits all” Dr Scientist—Immuno-Oncology Convergent Research - Senior Scientist, Cell-Based Assay Development Explore Dr

This week's GPCR paper features an innovative publication by Dr. Silvio Gutkind. July 21st marks our next Dr. Showcase your research by contacting us at Hello@DrGPCR.com Stay informed with Dr. Glioblastoma Associate Director / Director, Clinical Operations Postdoctoral Research Associate Explore Dr

Come to Dr. GPCR Ecosystem and create a course on your favorite #GPCR research, technique and more… Available for Dr

The program of the Dr. GPCR Summit from October 10th to the 16th is taking shape. Check it out today but first become a Dr. GPCR Ecosystem site member, which is free!

Dr. stay ahead of the science 🧠 Content built for biotech, pharma & academia 💬 Live monthly AMA with Dr Kenakin     💎 $2999/year — one conference cost = 12 months of expert training  Premium Dr.

Dr. Michel Bouvier, Dr. Luisa Salter-Cid, Dr. Omar Nadeem and Dr.

This week's GPCR papers feature a publication from Dr. Marta Filizola. Check it out! The Dr. For Dr. GPCR News, please subscribe to your monthly newsletter. Culture Scientist/Tissue Culture Manager Postdoctoral Researcher Director - Targeted Oncology Explore Dr

Dr. analogues for real-time binding studies of orphan GPCR GPR3: Save the dates: November 17: Join our final Dr You don't want to miss out on our monthly Dr. GPCR Newsletter for exclusive content, check out our latest video featuring Dr. Kathleen Caron. Crinetics Pharmaceuticals Senior Director, In vitro pharmacology - Crinetics Pharmaceuticals Explore Dr

pattern again and again—across academia, biotech, and through close work with dozens of teams inside the Dr Real-Time Global Insight As founder of Dr.

🌟 We're so excited about our upcoming Dr. GPCR Summit 2022. Join us now ➡️ https://www.ecosystem.drgpcr.com/dr-gpcr-summit-2022 #gpcr #drgpcr

This week's GPCR papers feature authors such as Drs. Dr. GPCR Symposium on GPCR Activation and Signaling, May 19th, 2023. Stay updated with the latest Dr. GPCR News by subscribing to our monthly newsletter. Fellow Research associate in protein production Vice President, Oncology Clinical Research Explore Dr

Hello Readers👋, We're excited to have you in the Dr. GPCR Ecosystem. For Dr. GPCR News, subscribe to our monthly newsletter. This month on the Dr. GPCR News video edition, we chatted with Dr. Oliver Hartley. Explore Dr. GPCR Ecosystem